Form D · Other Health Care

ConneX BioMedical, Inc.

Boulder, CO · CIK 0001865132

Offering snapshot reported Mar 17, 2023 · SEC filing

Reported sold
$5.16M
Offering amount: $5.5M
Investors reported
2
Form D · investor count
Minimum accepted
$100K
Reported outside-investor minimum
First sale
May 7, 2021
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$2.58M$5.16MJun 1, 2021: $1,000,000.00Jun 1, 2021Mar 17, 2023: $5,155,935.00Mar 17, 2023

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,000,000 → $5,155,935

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 17, 2023Amendment$5,155,935$4,155,935vs Jun 1, 20212SEC filing
Jun 1, 2021Initial$1,000,000No comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-401222

Source: Form D, filed Mar 17, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Christopher E Banas Director, Executive
Max B Mitchell Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
1434 Spruce Street Suite 100
Boulder, CO, 80302